Dr. Stephen M. Bloch - 22 Jun 2026 Form 4 Insider Report for Liquidia Corp (LQDA)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
24 Jun 2026, 16:30:15 UTC
Prior SEC filing
18 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Dr. Stephen M. Bloch

Key filing fact

Dr. Stephen M. Bloch filed Form 4 for Liquidia Corp (LQDA) on 24 Jun 2026.

Key facts

  • This page summarizes Dr. Stephen M. Bloch's Form 4 filing for Liquidia Corp (LQDA).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 24 Jun 2026, 16:30.

Change

  • Previous filing in this sequence was filed on 18 Jun 2026.
  • Current net transaction value: -$7,573,704.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001400308 Primary reporting owner

Bloch Stephen M

Relationship
Director
Address
419 DAVIS DRIVE, SUITE 100, MORRISVILLE
Signature
/s/ Dr. Stephen M. Bloch
Signature date
24 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

LQDA transaction

Common Stock

Sale

Transaction value
$5,250,287
Shares
-69,500
Change %
-7.1%
Price
$75.54
Shares after
910,573
Date
22 Jun 2026
Ownership
See footnote
Footnotes
F1, F2
LQDA transaction

Common Stock

Sale

Transaction value
$2,323,417
Shares
-30,500
Change %
-3.3%
Price
$76.18
Shares after
880,073
Date
22 Jun 2026
Ownership
See footnote
Footnotes
F2, F3
LQDA holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
71,594
Date
22 Jun 2026
Ownership
Direct
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $75.00 to $75.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Footnote F2

The securities are held directly by Canaan VIII L.P. ("Canaan LP"). Canaan Partners VIII LLC ("Canaan LLC" and together with Canaan LP, the "Canaan Entities") is the sole general partner of Canaan LP. Investment and voting decisions with respect to the securities held by Canaan LP are made by the managers of Canaan LLC, collectively. The Reporting Person disclaims beneficial ownership of the securities held by the Canaan Entities, except to the extent of his pecuniary interest, if any, in such securities by virtue of the limited liability company interests he owns in Canaan LLC. The Canaan Entities have instituted a communications-screen policy with respect to securities matters relating to the Issuer, and the Reporting Person did not participate in this investment decision.

Footnote F3

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $76.00 to $76.42, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .